These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3349482)

  • 1. Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys.
    Arndt CA; Balis FM; McCully CL; Colvin OM; Poplack DG
    Cancer Res; 1988 Apr; 48(8):2113-5. PubMed ID: 3349482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children.
    Yule SM; Price L; Pearson AD; Boddy AV
    Clin Cancer Res; 1997 Nov; 3(11):1985-92. PubMed ID: 9815588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys.
    Arndt CA; Colvin OM; Balis FM; Lester CM; Johnson G; Poplack DG
    Cancer Res; 1987 Nov; 47(22):5932-4. PubMed ID: 3664493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ifosfamide and some metabolites in children.
    Kaijser GP; De Kraker J; Bult A; Underberg WJ; Beijnen JH
    Anticancer Res; 1998; 18(3B):1941-9. PubMed ID: 9677448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of ifosfamide and its active metabolite 4-OH-ifosfamide into cerebrospinal fluid of patients with CNS malignancies.
    Kiewe P; Neumann M; Wagner T; Seyfert S; Albrecht H; Thiel E; Korfel A
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):27-33. PubMed ID: 20182727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification by gas chromatography of N,N'-di-(2-chloroethyl)-phosphorodiamidic acid in the plasma of patients receiving isophosphamide.
    Bryant BM; Jarman M; Baker MH; Smith IE; Smyth JF
    Cancer Res; 1980 Dec; 40(12):4734-8. PubMed ID: 7438105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantification of (R) and (S)-dechloroethylifosfamide metabolites in plasma from children by enantioselective LC/MS/MS.
    Aleksa K; Nava-Ocampo A; Koren G
    Chirality; 2009 Jul; 21(7):674-80. PubMed ID: 18825700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatographic determination of 2- and 3-dechloroethylifosfamide in plasma and urine.
    Kaijser GP; Beijnen JH; Bult A; Wiese G; de Kraker J; Keizer HJ; Underberg WJ
    J Chromatogr; 1992 Dec; 583(2):175-82. PubMed ID: 1478981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
    Kurowski V; Wagner T
    Cancer Chemother Pharmacol; 1993; 33(1):36-42. PubMed ID: 8269587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.
    Vela-Ojeda J; Tripp-Villanueva F; Montiel-Cervantes L; Sánchez-Cortés E; Ayala-Sánchez M; Guevara-Moreno ME; García-León LD; Rosas-Cabral A; Esparza MA; González-Llaven J
    Bone Marrow Transplant; 2000 Jun; 25(11):1141-6. PubMed ID: 10849526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates.
    Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG
    Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of 4-hydroxyifosfamide in plasma of ifosfamide-treated mice.
    Struck RF; McCain DM; Tendian SW; Tillery KH
    Cancer Chemother Pharmacol; 1997; 40(1):57-9. PubMed ID: 9137530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
    Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
    Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
    Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates.
    Berg SL; Stone J; Xiao JJ; Chan KK; Nuchtern J; Dauser R; McGuffey L; Thompson P; Blaney SM
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):85-8. PubMed ID: 15042312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.
    Jackson DV; Castle MC; Poplack DG; Bender RA
    Cancer Res; 1980 Mar; 40(3):722-4. PubMed ID: 7471091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma and urine of cancer patients treated with a 10-day continuous infusion of ifosfamide.
    Kaijser GP; Keizer HJ; Beijnen JH; Bult A; Underberg WJ
    Anticancer Res; 1996; 16(5B):3247-57. PubMed ID: 8920799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma.
    Zamboni WC; Gajjar AJ; Mandrell TD; Einhaus SL; Danks MK; Rogers WP; Heideman RL; Houghton PJ; Stewart CF
    Clin Cancer Res; 1998 Oct; 4(10):2537-44. PubMed ID: 9796988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys.
    Blatt J; Venner PM; Riccardi R; Cohen LF; Gangji D; Glazer RI; Poplack DG
    J Natl Cancer Inst; 1982 Mar; 68(3):391-3. PubMed ID: 6977672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test.
    Wagner T; Heydrich D; Jork T; Voelcker G; Hohorst HJ
    J Cancer Res Clin Oncol; 1981; 100(1):95-104. PubMed ID: 7240346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.